US Pharma MarketingMakary’s exit ends a turbulent run marred by leadership upheaval, mass layoffs, political pressure and public spats with drugmakers.
FDA chief Marty Makary resigns from agency, ending tumultuous tenure
FDA chief Marty Makary resigns from agency, ending tumultuous tenure is a pharma and life sciences industry update from BioPharma Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Source: BioPharma Dive